Home » Topics » BioWorld Science

BioWorld Science
RSS

First patients imaged in phase II expanded access study of 68Ga-PSMA-11

Aug. 13, 2018

Samsung Bioepis to soon begin phase I study of SB-26

Aug. 13, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

PARP inhibitors may be ALS drugs

Aug. 13, 2018

Researchers identify novel candidate genes involved in cognitive function

Aug. 13, 2018

Progranulin as a novel therapeutic target for the treatment of frontotemporal dementia

Aug. 13, 2018

Controlling HIV's reservoir

Aug. 13, 2018

TRK fusions actionable in blood cancers

Aug. 13, 2018

Preventing fat uptake by lymphatic system could be antiobesity approach

Aug. 13, 2018

MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...